Krajnak, Slavomir
Decker, Thomas
Schollenberger, Lukas
Rosé, Christian
Ruckes, Christian
Fehm, Tanja
Thomssen, Christoph
Harbeck, Nadia
Schmidt, Marcus http://orcid.org/0000-0003-1365-2414
Funding for this research was provided by:
Pierre-Fabre Pharma GmbH
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Article History
Received: 23 February 2021
Accepted: 12 March 2021
First Online: 20 March 2021
Declarations
:
: Slavomir Krajnak received speaker honoraria from Roche Pharma AG, research funding from Novartis and travel reimbursement from PharmaMar outside the submitted work. Thomas Decker reports personal fees from Lilly and Novartis outside the submitted work. Christian Rosé is an employee of Pierre-Fabre. Tanja Fehm received honoraria from Onkowissen, Pfizer, Novartis, Roche, MSD, Daichii Sankyo, AstraZeneca outside the submitted work. Christoph Thomssen received honoraria for advisory boards and lectures from Amgen, Astra-Zeneca, Celgene, Daiichi Sankyo, Eisai, Lilly, MSD, Nanostring, Novartis, Pfizer, Pierre Fabre, Puma, Roche, Vifor outside the submitted work; he received research support (by discount prizes) from American Diagnostica, Affymetrix, Nanostring. Nadia Harbeck received honoraria for consulting and/or lectures from Astra Zeneca, Daiichi-Sankyo, Lilly, MSD, Novartis, Pierre Fabre, Pfizer, Roche, Sandoz/Hexal, Seattle Genetics outside the submitted work. Marcus Schmidt reports grants from Pierre-Fable during the conduct of the study; he received honoraria for consulting and/or lectures from Amgen, AstraZeneca, Eisai, Lilly, Myelo Therapeutics, Novartis, Pantarhei Bioscience, Pfizer, Pierre-Fabre, Roche and Seattle Genetics outside the submitted work. He received research funding from AstraZeneca, BioNTech, Eisai, Genentech, German Breast Group, Myelo Therapeutics, Novartis, Palleos, Pantarhei Bioscience, Pierre-Fabre, and Roche. He received travel reimbursement from BioNTech, Pantarhei Bioscience, Pfizer and Roche; in addition, he has a patent for EP 2951317 B1 and a patent for EP 2390370 B1 issued. All other authors declare that they have no conflict of interest.
: All procedures performed in this study were in accordance with GCP, with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments. The study was approved by the ethics committee of the Landesärztekammer Rheinland-Pfalz and local ethics committee for each participating centre. Informed consent was obtained from all individual participants participating in the study.
: Informed consent to participate in the study was obtained from all participants.
: All participants consented to the publication of the study.